Clinical Trial

Multiparametric Characterization of Colorectal Cancers (METRAD)

Study acronym: METRAD
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary goal of this observational study is to assess the predictive value of a model developed through a multiparametric analysis of clinical images, histopathological data, CT scans, and molecular analysis. This analysis will be conducted on a retrospective cohort recruited at CHU Brest (training group). The model will then be validated using external cohorts from other centers (test group).
Trial Details
NCT Number NCT07000474
Lead Sponsor University Hospital, Brest
Conditions Colo-rectal Cancer
Enrollment 200 participants
Start Date 2025-03-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-03